Dr Theo de Malmanche

Brief Profile / Biography 

Theo de Malmanche trained in rheumatology and immunology, and is the director of the NSW Health Pathology North (Newcastle) Immunology laboratory.  Theo also has interests in the immunological aspects of trauma, encephalopathy and infection.  He set up genetic complement assays for microangiopathy testing and has presented on this topic, and on over-testing governance.   

He is currently chair of NSWHP immunology stream group, is a member of the combined AACB/RCPAQAP CSF Working Party, and some local initiatives.   

Like many pathologists, he spends most of his time trying to get the best quality results to the most clinicians in a way that is of most use to them and their patients. 

MB.ChB (Otago) (1994), FRACP (Rheumatology, Immunology, 2006), FRCPA (Immunopathology, 2006) 

 

Research Interests 

  • Immunology - cellular, humoral and molecular 
  • Quality use of pathology 

 

Why did you get into research? 

Research is the difference between what we do now and what is possible. Every day in health care we see things that could be done better, and research converts that from science fiction into history. 

 

What would be the ultimate goal for your research? 

Patient outcomes. We can make your time on this earth better, living or understanding better. We may be able to get up back to what matters faster, easier and cheaper. It might not be the same, but we will try. 

 

Future Focus 

Our teams in Newcastle are not beleaguered by historical biases. We can use the dynamic collaboration possible in Newcastle to realise opportunities that science and our experts provides, with results within years, not decades. Collaboration here is simple and effective. We get things done. 

 

Specialised/Technical Skills  

Has a current working knowledge of modern immunopathology and molecular pathology. Currently reporting immunopathology and genomic pathology results for patients, within RCPA scope of practice. 

Directs one of the largest diagnostic flow cytometry units in Australia, which includes adult and paediatric patient samples.  

Interpretation of immunogenetics and histocompatibility (serological, cell based and molecular). 

 

Affiliations 

  • Australasian Rheumatology Association 2002 - present 
  • American College of Rheumatology 2008 - present 
  • Australasian Society for Clinical Immunology and Allergy 2004 - present 
  • Australian Association of Consultant Physicians 2010 - present 
  • European Society for Clinical Cell Analysis 2010 – present 
  • International Encephalitis Consortium 2015 – 2016 
  • ASCIA ENA Working Party 2007-2008 
  • RCPA QAP CSF Working Party 2008 – present 
  • RCPA QAP HLA-DQ typing Working Party 2021-present 
  • RACP/RCPA Immunology & Allergy JSAC / JCTC 2010-2016